Based on the Curtis Breast Statistics dataset, CEMIP transcripts were elevated 2.465-fold in BC samples when compared with normal breast tissues (P = 1.11 × 10-14) 25 (Figure 1C) and were 2.926-fold elevated in ductal carcinoma in situ samples as compared with normal tissues (P = 2.48 × 10-7) in Gluck's study 26 (Figure 1D). The gene discussed is CEMIP; the disease is ductal breast carcinoma in situ.